Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epoetin”

678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 678 results

Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Not applicableStudy completedNCT03231085
What this trial is testing

Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child

Who this might be right for
Craniosynostosis
University Hospital, Montpellier 100
Not applicableStudy completedNCT01666301
What this trial is testing

ESAs, Reticulocyte Dynamic and Hemoglobin Variability

Who this might be right for
Erythropoiesis Stimulating Agent Pharmacodynamics
Ospedale Regionale di Locarno 31
Large-scale testing (Phase 3)Study completedNCT00270166
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Who this might be right for
AnemiaMultiple MyelomaLymphoma+6 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Large-scale testing (Phase 3)Study completedNCT00737477
What this trial is testing

Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)UnknownNCT01889056
What this trial is testing

Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in Humans

Who this might be right for
Healthy
University of Zurich 32
Large-scale testing (Phase 3)Study completedNCT00223977
What this trial is testing

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Who this might be right for
Iron Deficiency Anemia
Watson Pharmaceuticals 146
Testing effectiveness (Phase 2)WithdrawnNCT02431351
What this trial is testing

Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients

Who this might be right for
Myelodysplastic Syndrome
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Study completedNCT00212875
What this trial is testing

Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.

Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267
Testing effectiveness (Phase 2)Study completedNCT01194154
What this trial is testing

Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)

Who this might be right for
Kidney Disease, Chronic
Hoffmann-La Roche 241
Large-scale testing (Phase 3)Study completedNCT02827266
What this trial is testing

Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 122
Large-scale testing (Phase 3)Study completedNCT00270127
What this trial is testing

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

Who this might be right for
AnemiaCancerNeoplasm
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375
Large-scale testing (Phase 3)Study completedNCT00666835
What this trial is testing

Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

Who this might be right for
Anemia
Sandoz 478
Large-scale testing (Phase 3)Ended earlyNCT00246597
What this trial is testing

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

Who this might be right for
AnemiaBreast NeoplasmsHemoglobins+2 more
Ortho Biotech Products, L.P. 37
Testing effectiveness (Phase 2)Study completedNCT01244763
What this trial is testing

Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

Who this might be right for
Chronic Kidney DiseaseAnemia
Kyntra Bio 145
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Large-scale testing (Phase 3)Study completedNCT00605293
What this trial is testing

Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 101
Not applicableEnded earlyNCT00875004
What this trial is testing

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
AnemiaUnspecified Adult Solid Tumor, Protocol Specific
Institut du Cancer de Montpellier - Val d'Aurelle 27
Not applicableStudy completedNCT01320449
What this trial is testing

Identification of New Serum Markers for Detection of Abuse With Erythropoietin

Who this might be right for
Substance Abuse Problem
University of Aarhus 35
Load More Results